Yifan Tu

2.3k total citations
50 papers, 1.6k citations indexed

About

Yifan Tu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yifan Tu has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Surgery. Recurrent topics in Yifan Tu's work include RNA Interference and Gene Delivery (4 papers), Retinoids in leukemia and cellular processes (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Yifan Tu is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Retinoids in leukemia and cellular processes (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Yifan Tu collaborates with scholars based in United States, China and Hong Kong. Yifan Tu's co-authors include Zhongyang Liu, Xiaoling Gao, Qingxiang Song, Guangzhi Gu, Quanyin Hu, Xinguo Jiang, Ting Kang, Hongzhuan Chen, Zhiqing Pang and Rongzhu Lu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Environmental Science & Technology.

In The Last Decade

Yifan Tu

46 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifan Tu United States 18 715 436 275 217 164 50 1.6k
Si Chen China 26 952 1.3× 102 0.2× 128 0.5× 219 1.0× 91 0.6× 83 2.0k
Ana Savić-Radojević Serbia 24 929 1.3× 131 0.3× 131 0.5× 110 0.5× 33 0.2× 90 2.0k
Yue Yang China 28 821 1.1× 171 0.4× 143 0.5× 193 0.9× 116 0.7× 93 1.8k
Virgil Păunescu Romania 22 408 0.6× 118 0.3× 106 0.4× 257 1.2× 60 0.4× 102 1.5k
Chao Luo China 22 501 0.7× 196 0.4× 209 0.8× 164 0.8× 57 0.3× 60 1.4k
Kyung Chan Park South Korea 25 812 1.1× 81 0.2× 128 0.5× 382 1.8× 34 0.2× 45 2.3k
Yhun Yhong Sheen South Korea 28 1.4k 2.0× 119 0.3× 117 0.4× 757 3.5× 45 0.3× 76 2.7k
Donghui Zheng China 24 667 0.9× 169 0.4× 325 1.2× 131 0.6× 46 0.3× 62 1.5k
Yanfang Zheng China 26 963 1.3× 123 0.3× 144 0.5× 334 1.5× 45 0.3× 102 1.8k

Countries citing papers authored by Yifan Tu

Since Specialization
Citations

This map shows the geographic impact of Yifan Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Tu more than expected).

Fields of papers citing papers by Yifan Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifan Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Tu. The network helps show where Yifan Tu may publish in the future.

Co-authorship network of co-authors of Yifan Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yifan Tu. A scholar is included among the top collaborators of Yifan Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifan Tu. Yifan Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Chunhua, Xiao Jin Jiang, Wenjie Pan, et al.. (2025). Accurate Accounting and Molecular Composition Analysis Reveal Sargassum Beds as a Major Marine Carbon Sequestration. Environmental Science & Technology. 59(32). 16985–16996.
2.
3.
Yang, Chao‐Yu, Yifan Tu, Li‐Chung Hsu, et al.. (2024). Reverse hierarchical DED assembly in the cFLIP-procaspase-8 and cFLIP-procaspase-8-FADD complexes. Nature Communications. 15(1). 8974–8974. 2 indexed citations
4.
Yan, Han, Yaqiong Wang, Yifan Tu, et al.. (2024). Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes. Cardiovascular Diabetology. 23(1). 142–142. 28 indexed citations
5.
Yang, Chao‐Yu, Yifan Tu, Arkadiusz W. Kulczyk, et al.. (2024). Deciphering DED assembly mechanisms in FADD-procaspase-8-cFLIP complexes regulating apoptosis. Nature Communications. 15(1). 3791–3791. 12 indexed citations
6.
Chen, Jin-Yuan, et al.. (2023). Experimental and computational models to investigate intestinal drug permeability and metabolism. Xenobiotica. 53(1). 25–45. 3 indexed citations
8.
Guo, Chun, Chunfa Huang, Madeline Wong, et al.. (2019). Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML. Blood Advances. 3(9). 1379–1393. 12 indexed citations
10.
He, Yu, Song Gao, Taijun Yin, et al.. (2017). Development and validation of a sensitive LC–MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 148. 65–72. 23 indexed citations
11.
Ge, Shufan, Yifan Tu, & Ming Hu. (2016). Challenges and Opportunities with Predicting In Vivo Phase II Metabolism via Glucuronidation From In Vitro Data. Current Pharmacology Reports. 2(6). 326–338. 22 indexed citations
12.
Yin, Taijun, et al.. (2016). Determination of 7α-OH cholesterol by LC–MS/MS: Application in assessing the activity of CYP7A1 in cholestatic minipigs. Journal of Chromatography B. 1025. 76–82. 7 indexed citations
13.
Tu, Yifan, Dawn L. Hershman, Kapil N. Bhalla, et al.. (2014). A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Research and Treatment. 146(1). 145–152. 51 indexed citations
14.
Kalinsky, Kevin, Emerson A. Lim, Eleni Andreopoulou, et al.. (2014). Increased Expression of Tumor Proliferation Genes in Hispanic Women with Early-Stage Breast Cancer. Cancer Investigation. 32(9). 439–444. 10 indexed citations
15.
Hu, Quanyin, Xiaoling Gao, Guangzhi Gu, et al.. (2013). Glioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxel. Biomaterials. 34(22). 5640–5650. 148 indexed citations
16.
Liu, Zhongyang, Mengyin Jiang, Ting Kang, et al.. (2013). Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Biomaterials. 34(15). 3870–3881. 160 indexed citations
17.
Hu, Quanyin, Guangzhi Gu, Zhongyang Liu, et al.. (2012). F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Biomaterials. 34(4). 1135–1145. 164 indexed citations
18.
Xia, Huimin, Xiaoling Gao, Guangzhi Gu, et al.. (2012). Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery. International Journal of Pharmaceutics. 436(1-2). 840–850. 125 indexed citations
19.
Tu, Yifan, Louis A. Roberts, Kalidas Shetty, & Sallie S. Schneider. (2008). Rhodiola crenulata Induces Death and Inhibits Growth of Breast Cancer Cell Lines. Journal of Medicinal Food. 11(3). 413–423. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026